264 related articles for article (PubMed ID: 36423635)
1. Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1
Hua Y; Vella G; Rambow F; Allen E; Antoranz Martinez A; Duhamel M; Takeda A; Jalkanen S; Junius S; Smeets A; Nittner D; Dimmeler S; Hehlgans T; Liston A; Bosisio FM; Floris G; Laoui D; Hollmén M; Lambrechts D; Merchiers P; Marine JC; Schlenner S; Bergers G
Cancer Cell; 2022 Dec; 40(12):1600-1618.e10. PubMed ID: 36423635
[TBL] [Abstract][Full Text] [Related]
2. High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer.
Vella G; Guelfi S; Bergers G
Front Immunol; 2021; 12():736670. PubMed ID: 34484246
[TBL] [Abstract][Full Text] [Related]
3. High endothelial venules in cancer: Regulation, function, and therapeutic implication.
Vella G; Hua Y; Bergers G
Cancer Cell; 2023 Mar; 41(3):527-545. PubMed ID: 36827979
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy.
Asrir A; Tardiveau C; Coudert J; Laffont R; Blanchard L; Bellard E; Veerman K; Bettini S; Lafouresse F; Vina E; Tarroux D; Roy S; Girault I; Molinaro I; Martins F; Scoazec JY; Ortega N; Robert C; Girard JP
Cancer Cell; 2022 Mar; 40(3):318-334.e9. PubMed ID: 35120598
[TBL] [Abstract][Full Text] [Related]
5. High endothelial venules (HEVs) in immunity, inflammation and cancer.
Blanchard L; Girard JP
Angiogenesis; 2021 Nov; 24(4):719-753. PubMed ID: 33956259
[TBL] [Abstract][Full Text] [Related]
6. Understanding high endothelial venules: Lessons for cancer immunology.
Ager A; May MJ
Oncoimmunology; 2015 Jun; 4(6):e1008791. PubMed ID: 26155419
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint ligands expressed on mature high endothelial venules predict poor prognosis of NSCLC: have a relationship with CD8
Luo J; Shi X; Liu Y; Wang J; Wang H; Yang X; Sun Q; Hui Z; Wei F; Ren X; Zhao H
Front Immunol; 2024; 15():1302761. PubMed ID: 38390332
[TBL] [Abstract][Full Text] [Related]
8. High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer.
Martinet L; Filleron T; Le Guellec S; Rochaix P; Garrido I; Girard JP
J Immunol; 2013 Aug; 191(4):2001-8. PubMed ID: 23825314
[TBL] [Abstract][Full Text] [Related]
9. High endothelial venules in intracranial germinomas: Implications for lymphocytes infiltration.
Chen H; Li G; Cui Y; Zhang Q; Li B; Liu X
Cancer Med; 2023 Mar; 12(5):5450-5460. PubMed ID: 36259639
[TBL] [Abstract][Full Text] [Related]
10. Single-Cell Analysis Reveals Heterogeneity of High Endothelial Venules and Different Regulation of Genes Controlling Lymphocyte Entry to Lymph Nodes.
Veerman K; Tardiveau C; Martins F; Coudert J; Girard JP
Cell Rep; 2019 Mar; 26(11):3116-3131.e5. PubMed ID: 30865898
[TBL] [Abstract][Full Text] [Related]
11. Endothelial cell-specific lymphotoxin-β receptor signaling is critical for lymph node and high endothelial venule formation.
Onder L; Danuser R; Scandella E; Firner S; Chai Q; Hehlgans T; Stein JV; Ludewig B
J Exp Med; 2013 Mar; 210(3):465-73. PubMed ID: 23420877
[TBL] [Abstract][Full Text] [Related]
12. Molecular Signature of Tumor-Associated High Endothelial Venules That Can Predict Breast Cancer Survival.
Sawada J; Hiraoka N; Qi R; Jiang L; Fournier-Goss AE; Yoshida M; Kawashima H; Komatsu M
Cancer Immunol Res; 2022 Apr; 10(4):468-481. PubMed ID: 35201289
[TBL] [Abstract][Full Text] [Related]
13. The link between T cell activation and development of functionally useful tumour-associated high endothelial venules.
Milutinovic S; Gallimore A
Discov Immunol; 2023; 2(1):kyad006. PubMed ID: 37287625
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte access to lymphoma is impaired by high endothelial venule regression.
Menzel L; Zschummel M; Crowley T; Franke V; Grau M; Ulbricht C; Hauser A; Siffrin V; Bajénoff M; Acton SE; Akalin A; Lenz G; Willimsky G; Höpken UE; Rehm A
Cell Rep; 2021 Oct; 37(4):109878. PubMed ID: 34706240
[TBL] [Abstract][Full Text] [Related]
15. High endothelial venules as potential gateways for therapeutics.
Hussain B; Kasinath V; Ashton-Rickardt GP; Clancy T; Uchimura K; Tsokos G; Abdi R
Trends Immunol; 2022 Sep; 43(9):728-740. PubMed ID: 35931612
[TBL] [Abstract][Full Text] [Related]
16. High endothelial venules predict response to PD-1 inhibitors combined with anti-angiogenesis therapy in NSCLC.
Ye D; Jin Y; Weng Y; Cui X; Wang J; Peng M; Song Q
Sci Rep; 2023 Sep; 13(1):16468. PubMed ID: 37777573
[TBL] [Abstract][Full Text] [Related]
17. High endothelial venules associated with T cell subsets in the inflamed gut of newly diagnosed inflammatory bowel disease patients.
Horjus Talabur Horje CS; Smids C; Meijer JW; Groenen MJ; Rijnders MK; van Lochem EG; Wahab PJ
Clin Exp Immunol; 2017 Apr; 188(1):163-173. PubMed ID: 28033681
[TBL] [Abstract][Full Text] [Related]
18. High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer.
Park HS; Kim YM; Kim S; Lee WS; Kong SJ; Yang H; Kang B; Cheon J; Shin SJ; Kim C; Chon HJ
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34670828
[TBL] [Abstract][Full Text] [Related]
19. Regulation, Maintenance, and Remodeling of High Endothelial Venules in Homeostasis, Inflammation, and Cancer.
Ruddle NH
Curr Opin Physiol; 2023 Dec; 36():. PubMed ID: 38523879
[TBL] [Abstract][Full Text] [Related]
20. Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation.
Allen E; Jabouille A; Rivera LB; Lodewijckx I; Missiaen R; Steri V; Feyen K; Tawney J; Hanahan D; Michael IP; Bergers G
Sci Transl Med; 2017 Apr; 9(385):. PubMed ID: 28404866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
